Literature DB >> 15258784

Cerebral microembolism during transcatheter closure of patent foramen ovale.

J Ferrari1, H Baumgartner, S Tentschert, V Dorda, W Lang, A Willfort-Ehringer, P Probst, W Lalouschek.   

Abstract

BACKGROUND: Although transcatheter closure of patent foramen ovale (PFO) and atrial septal defect (ASD) has become a commonly performed intervention, the incidence of cerebral embolism with or without neurological deficits during such procedures has not been studied.
METHODS: We monitored the middle cerebral artery in two different depths (48 mm and 53 mm) by continuous transcranial Doppler ultrasound during transcatheter PFO closure in 35 consecutive patients (F/M 20/15, mean age 47 +/- 11 years) and during ASD closure in 8 patients (F/M 7/1, mean age 45 +/- 5 years). All automatically detected high intensity transient signals (HITS) were manually reviewed to eliminate artifacts.
RESULTS: HITS were detected in 33 of 35 patients (96%) with a median rate of 8 (interquartile range 4-19, range 2-29) HITS. The highest rates were observed when the septum was crossed with the guide wire (median 2; IQR 0-12; range 0-25) and when the left atrial disc was deployed (median 2; IQR 1-4; range 0-13). Despite this high rate of cerebral microembolism no clinically apparent neurological or neuropsychological deficit was observed.
CONCLUSIONS: Silent cerebral embolism frequently occurs during transcatheter PFO and ASD closure. The peak of HITS at the time of crossing the septum with the guide wire may support the hypothesis that cerebral emboli in patients with PFO may originate from the septum itself. This may represent an alternative mechanism to the generally assumed paradoxical embolism.

Entities:  

Mesh:

Year:  2004        PMID: 15258784     DOI: 10.1007/s00415-004-0435-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism.

Authors:  A Wahl; B Meier; B Haxel; K Nedeltchev; M Arnold; E Eicher; M Sturzenegger; C Seiler; H P Mattle; S Windecker
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

2.  Transcranial Doppler detection of cerebral microemboli during left heart catheterization.

Authors:  F Leclercq; S Kassnasrallah; J B Cesari; J M Blard; J C Macia; P Messner-Pellenc; C J Mariottini; R Grolleau-Raoux
Journal:  Cerebrovasc Dis       Date:  2001       Impact factor: 2.762

3.  Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism.

Authors:  D J Ende; P S Chopra; P S Rao
Journal:  Am J Cardiol       Date:  1996-07-15       Impact factor: 2.778

4.  Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group.

Authors:  J Bogousslavsky; S Garazi; X Jeanrenaud; N Aebischer; G Van Melle
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

5.  Double-umbrella device for transvenous closure of patent ductus arteriosus and atrial septal defect: first experience.

Authors:  U U Babic; S Grujicic; Z Popovic; Z Djurisic; M Vucinic; P Pejcic
Journal:  J Interv Cardiol       Date:  1991       Impact factor: 2.279

6.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.

Authors:  J L Mas; C Arquizan; C Lamy; M Zuber; L Cabanes; G Derumeaux; J Coste
Journal:  N Engl J Med       Date:  2001-12-13       Impact factor: 91.245

7.  Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack.

Authors:  H Lethen; F A Flachskampf; R Schneider; U Sliwka; G Köhn; J Noth; P Hanrath
Journal:  Am J Cardiol       Date:  1997-10-15       Impact factor: 2.778

8.  Transcranial Doppler detection of microemboli during percutaneous transluminal coronary angioplasty.

Authors:  C F Bladin; L Bingham; L Grigg; A G Yapanis; R Gerraty; S M Davis
Journal:  Stroke       Date:  1998-11       Impact factor: 7.914

9.  Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial).

Authors:  H Sievert; U U Babic; G Hausdorf; M Schneider; H W Höpp; D Pfeiffer; M Pfisterer; B Friedli; P Urban
Journal:  Am J Cardiol       Date:  1998-12-01       Impact factor: 2.778

10.  Patent foramen ovale: is stroke due to paradoxical embolism?

Authors:  D Ranoux; A Cohen; L Cabanes; P Amarenco; M G Bousser; J L Mas
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  4 in total

1.  Patent foramen ovale: the never-ending story.

Authors:  Gérald Devuyst; Julien Bogousslavsky
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

2.  Silent cerebral emboli following percutaneous closure of atrial septal defect in pediatric patients: a diffusion-weighted MRI study.

Authors:  Gonca Koç; Abdullah Özyurt; Selim Doğanay; Ali Baykan; S Burcu Görkem; M Sait Doğan; Özge Pamukçu; Kazım Üzüm; Abdulhakim Coşkun; Nazmi Narin
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

3.  Migraine: traditional or "innovative" treatment? A preliminary case-control study.

Authors:  E Morandi; G P Anzola; F Casilli; E Onorato
Journal:  Pediatr Cardiol       Date:  2005 May-Jun       Impact factor: 1.655

4.  Cerebral Microemboli Detection and Differentiation During Transcatheter Closure of Patent Ductus Arteriosus.

Authors:  Sean Wallace; Gaute Døhlen; Henrik Holmstrøm; Christian Lund; David Russell
Journal:  Pediatr Cardiol       Date:  2016-05-26       Impact factor: 1.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.